Contineum Therapeutics (CTNM) logo

CTNM earnings date, and what happened the last 4 times

Next report

Thu Oct 29

Quality Score today -7

After the close, in 2 days. Expected: the company has not confirmed it.

CTNM closed higher after 3 of its last 4 reports. On average it closed +1.8% the session after a report.

The moment CTNM reports

  • Its figures, in plain words
  • How it moves after, beside its last four
  • Its Quality Score going in, and after
Get an alert when CTNM reports, with its figures

See it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

What happened after CTNM's last 4 reports

CTNM's last 4 earnings reports
ReportedScore
going in
GapReaction
Jul 30, 20262026 · After close9estimated0.0%-1.6%
May 5, 20262026 · After close9estimated+0.7%+3.8%
Mar 5, 20262026 · After close6estimated+6.5%+0.5%
Oct 30, 20252025 · After close4estimated+0.8%+4.5%
  • Jul 30, 2026, after the close: the next session CTNM opened 0.0% and closed -1.6%, and five sessions on it stood -2.5%. Its Quality Score going in was 9 (Average), estimated.
  • May 5, 2026, after the close: the next session CTNM opened +0.7% and closed +3.8%, and five sessions on it stood -5.1%. Its Quality Score going in was 9 (Average), estimated.
  • Mar 5, 2026, after the close: the next session CTNM opened +6.5% and closed +0.5%, and five sessions on it stood +0.4%. Its Quality Score going in was 6 (Average), estimated.
  • Oct 30, 2025, after the close: the next session CTNM opened +0.8% and closed +4.5%, and five sessions on it stood +4.5%. Its Quality Score going in was 4 (Below Average), estimated.

Across these 4 reports CTNM opened higher after 3 of 4 and closed higher after 3 of 4; on average it opened +2.0%, closed +1.8%, and stood -0.7% five sessions on. Its Quality Score is -7 today, against 9 going into its Jul 30, 2026 report.

Gap: where the stock opened the session after the report. Reaction: where that session closed. Both against the close before the report. The largest of the 4: +4.5% after the Oct 30, 2025 report. A score marked estimated was worked out afterwards from that day's prices and filings; Breakaway has recorded every score live since Sep 9 2026.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Pro members see CTNM's reaction live as a report comes out, the release's figures, and an optional alert before it reports.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Questions about CTNM's earnings

As of Oct 27, 2026: Contineum Therapeutics (CTNM): expected to report Thu Oct 29, after the close. CTNM closed higher after 3 of its last 4 reports. Its Quality Score is -7 (Poor). Scores as of 12:12 AM ET, 15 minutes behind.

When is CTNM's next earnings date?

Expected to report Thu Oct 29, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it. CTNM closed higher after 3 of its last 4 reports. Past behavior, not a forecast.

Does CTNM report before or after the market?

CTNM is expected to report Thu Oct 29, after the close. Its last 4 reports came after the close.

How did CTNM stock react to its last earnings report?

Jul 30, 2026, after the close: the next session CTNM opened 0.0% and closed -1.6%, and five sessions on it stood -2.5%.

Does CTNM stock usually go up after earnings?

CTNM closed higher after 3 of its last 4 reports. On average it closed +1.8% the session after a report, after opening +2.0%. Past behavior, not a forecast.

Contineum Therapeutics' page has its Quality Score, its chart, and its insiders' trades. Everyone reporting beside it: this week's earnings.

Past behavior, not a forecast. The score is delayed at least 15 minutes; the reports' moves are as they closed.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.